Valuation Daiichi Sankyo Company, Limited

Equities

4568

JP3475350009

Pharmaceuticals

Market Closed - Japan Exchange Other stock markets 02:30:00 2026-03-13 am EDT			5-day change	1st Jan Change
2,818.50 ^JPY	-2.81%		-1.69%	-15.82%

Mar. 09	AstraZeneca and Daiichi Sankyo Enter Global Collaboration to Jointly Develop and Commercialize Enhertu	CI
Mar. 09	UK Shares Start Week in Red as Oil Prices Surge Amid US-Iran War	MT

Company Valuation: Daiichi Sankyo Company, Limited

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	6,179,276	5,136,821	9,244,546	9,159,669	6,590,893	5,207,614	-	-
Change	-	-16.87%	79.97%	-0.92%	-28.04%	-20.99%	-	-
Enterprise Value (EV) ¹	5,538,193	4,456,437	8,995,480	8,614,202	6,052,387	4,707,628	4,727,881	4,687,727
Change	-	-19.53%	101.85%	-4.24%	-29.74%	-22.22%	0.43%	-0.85%
P/E ratio	82.3x	76.7x	84.7x	45.6x	22.5x	16.7x	15x	12.8x
PBR	4.86x	3.8x	6.39x	5.43x	4.1x	2.82x	2.64x	2.33x
PEG	-	-7.1x	1.3x	0.5x	0.5x	2.11x	1.3x	0.8x
Capitalization / Revenue	6.42x	4.92x	7.23x	5.72x	3.49x	2.45x	2.23x	2.01x
EV / Revenue	5.75x	4.26x	7.04x	5.38x	3.21x	2.21x	2.03x	1.81x
EV / EBITDA	45.7x	33.9x	47.8x	31.8x	15.1x	11x	9.72x	8.84x
EV / EBIT	86.8x	61x	74.6x	40.7x	18.2x	13.2x	11.5x	9.76x
EV / FCF	36.2x	58.3x	-62.8x	27.2x	-97x	17x	22.2x	17.5x
FCF Yield	2.76%	1.72%	-1.59%	3.68%	-1.03%	5.87%	4.5%	5.71%
Dividend per Share ²	27	27	30	50	60	78.15	84.18	90.52
Rate of return	0.84%	1.01%	0.62%	1.05%	1.71%	2.77%	2.99%	3.21%
EPS ²	39.17	34.94	56.96	104.7	156	168.3	188.4	220.2
Distribution rate	68.9%	77.3%	52.7%	47.8%	38.5%	46.4%	44.7%	41.1%
Net sales ¹	962,516	1,044,900	1,278,478	1,601,700	1,886,256	2,125,410	2,332,203	2,588,793
EBITDA ¹	121,177	131,270	188,369	271,234	400,574	428,912	486,204	530,004
EBIT ¹	63,795	73,000	120,580	211,600	331,925	355,651	409,667	480,314
Net income ¹	75,958	67,000	109,188	200,700	295,756	310,870	347,495	403,431
Net Debt ¹	-641,083	-680,384	-249,066	-545,467	-538,506	-499,986	-479,732	-519,886
Reference price ²	3,225.00	2,680.00	4,822.00	4,777.00	3,511.00	2,818.50	2,818.50	2,818.50
Nbr of stocks (in thousands)	1,916,055	1,916,724	1,917,160	1,917,452	1,877,212	1,847,654	-	-
Announcement Date	4/27/21	4/27/22	4/27/23	4/25/24	4/25/25	-	-	-

¹JPY in Million²JPY

Estimates

P/E ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DAIICHI SANKYO COMPANY, LIMITED	16.75x	2.21x	10.98x	2.77%	32.63B
ELI LILLY AND COMPANY	28.95x	10.91x	21.91x	0.67%	880B
JOHNSON & JOHNSON	25.63x	5.96x	16.23x	2.19%	582B
ABBVIE INC.	24x	6.55x	13.15x	3.16%	388B
ROCHE HOLDING AG	17.32x	4.22x	10.43x	3.13%	324B
ASTRAZENECA PLC	23.94x	4.98x	13.83x	1.75%	295B
NOVARTIS AG	20.93x	5.64x	13.96x	2.87%	293B
MERCK & CO., INC.	27.02x	4.74x	14.82x	2.92%	286B
AMGEN INC.	24.64x	6.26x	11.14x	2.74%	197B
GILEAD SCIENCES, INC.	20.1x	6.12x	11.06x	2.25%	180B
Average	22.93x	5.76x	13.75x	2.45%	345.88B
Weighted average by Cap.	24.66x	6.90x	15.66x	2.12%